Background: In Japan, hepatitis E is considered as "imported infection" by travelers back from endemic areas or zoonotic transmission by eating law meat of pigs, boars, deer et al. Recently, we can identificate the location of HEV infection by molecular epidemiological approach. We will describe a Japanese case of imported hepatitis E and usefulness of molecular approach. Case: A 56-year-old man was admitted to Kato City Hospital with jaundice, fever and general malaise on November 26, 2007. He had worked in China (Mushaku City) for four years and four days before he came back to Japan and felt abnormal condition. Laboratory tests showed abnormal liver function tests (AST 5456 IU/l, ALT 5236 IU/l, TB1.72mg/dl, PT 55%). The skin appeared jaundiced and eruptions. Conservative management improved his conditions and laboratory data and he was discharged one month later. He had IgM class antibodies to HEV and detectable HEV RNA of genotype IV. Its nucleotide sequences of HEV showed quite a high degree of similarity to the reported in China.
Analysis and Conclusion:
In Japan, 23 imported hepatitis E cases were previously reported and 15 cases were checked HEV genotype by PCR. There were mainly two patterns. One was infected in India-Nepal-Pakistan area and all belongs to genotype I. The other was infected in China and genotype IV. As the Japanese travelers to abroad increased, the number of the imported cases with hepatitis E will be increased. But identification of the infected location was possible. Results: Eighty-nine patients with active pulmonary TB receiving initial anti-TB treatment were divided into 3 subgroups: 0-1 mo, 1-3 mo and 3-6 mo, in which the positive rates of T-SPOT.TB assay were 94.4%, 86.4% and 61.5%, respectively. The positive rate of T-SPOT.TB assay declined with the duration of anti-TB treatment, which was significantly lower in 3-6 mo group than in 0-1 mo group (P<0.005). Forty-one ATB patients with anti-TB treatment equal or shorter than 1 month were divided into two subgroups based on the results of acid-fast smear of sputum and M.tb culture: Bacteriology (+) and Bacteriology (-). The positive rate of T-SPOT.TB assay in Bacteriology (+) group was similar to that in Bacteriology (-) group (93.10% vs. 100.00%, P=1.000), whereas HC group had the lowest positive rate of T-SPOT.TB assay (21.05%, P=0.000). Conclusion: Interferon-γ-release assays (IGRAs) may act as a predictive marker for anti-TB treatment in both active and latent TB infection and the bacterial status of ATB patient doesn't affect IGRA results.
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